TB Immunity Research Paves the Way for Innovative Therapies and Prevention Strategies
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (MTB), remains a formidable global health challenge. As of 2022, TB was the second leading infectious killer worldwide, claiming 1.3 million lives, following COVID-19. Despite medical advancements, TB continues to pose significant problems due to rising drug resistance and the demands of prolonged treatment regimens. Following a […]
TB Immunity Research Paves the Way for Innovative Therapies and Prevention Strategies Read More »